Insider Trading activities of Foundation Medicine, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Foundation Medicine, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Foundation Medicine, Inc. since year 2005. Table 2 shows the detailed insider transactions of Foundation Medicine, Inc. since 2005. The reporting company's ticker symbol is FMI. The reporting company's CIK number is 1488613.
The total value of stock buying since 2005 is $780,363,958.
The total value of stock sales since 2005 is $326,922,539.
The total value of stock option exercises since 2005 is $5,602,627.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Foundation Medicine, Inc. (FMI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-07 0 $0 15,911 $2,174,394 0 $0
2018-06 0 $0 3,500 $369,075 0 $0
2018-05 0 $0 14,290 $1,060,409 1,570 $47,005
2018-04 0 $0 44,302 $3,257,088 2,344 $16,689
2018-03 0 $0 18,500 $1,447,915 15,000 $444,450
2018-02 0 $0 186,534 $13,434,217 40,630 $920,017
2018-01 0 $0 127,291 $8,363,172 52,529 $634,531
2017-12 0 $0 134,146 $8,155,493 27,500 $102,232
2017-11 0 $0 9,731 $486,550 0 $0
2017-10 0 $0 25,766 $1,026,478 0 $0
2017-08 0 $0 99,744 $3,895,045 60,257 $1,366,483
2017-07 0 $0 75,906 $2,958,288 0 $0
2017-06 0 $0 6,128 $244,176 7,033 $39,666
2017-05 0 $0 1,009 $34,174 0 $0
2017-04 0 $0 14,654 $481,049 0 $0
2017-03 0 $0 59,272 $1,979,038 52,500 $316,049
2017-02 0 $0 10,415 $242,044 0 $0
2017-01 0 $0 44,021 $782,568 0 $0
2016-11 0 $0 7,273 $167,366 7,273 $30,255
2016-10 0 $0 15,524 $363,434 0 $0
2016-09 0 $0 10,020 $235,699 7,850 $32,656
2016-08 0 $0 23,863 $573,272 24,377 $130,086
2016-07 0 $0 35,883 $633,338 0 $0
2016-06 0 $0 472 $10,223 0 $0
2016-04 0 $0 480 $8,677 0 $0
2016-03 0 $0 701 $10,613 0 $0
2016-01 0 $0 440 $8,746 0 $0
2015-12 0 $0 2,559 $42,947 0 $0
2015-11 9,100 $149,558 0 $0 0 $0
2015-10 0 $0 420 $7,676 0 $0
2015-07 0 $0 419 $14,203 4,687 $26,434
2015-06 0 $0 367,720 $12,125,942 0 $0
2015-05 0 $0 34,700 $1,367,639 0 $0
2015-04 15,604,288 $780,214,400 4,211,283 $210,563,186 0 $0
2015-03 0 $0 227,041 $10,771,211 358,630 $1,131,496
2015-02 0 $0 42,500 $2,040,127 25,000 $76,250
2015-01 0 $0 58,921 $2,861,774 23,000 $141,560
2014-12 0 $0 14,861 $349,804 2,361 $188
2014-11 0 $0 16,041 $399,559 3,541 $283
2014-10 0 $0 31,712 $748,919 14,721 $41,976
2014-09 0 $0 2,361 $51,750 2,361 $188
2014-08 0 $0 16,041 $405,048 3,541 $283
2014-07 0 $0 48,026 $1,313,478 13,541 $41,883
2014-06 0 $0 1,354,221 $30,418,207 29,221 $61,496
2014-05 0 $0 5,361 $139,451 2,361 $188
2014-04 0 $0 33,541 $899,077 3,541 $283

Table 2. Detailed insider stock purchases, sales, and option exercises of Foundation Medicine, Inc. insiders (FMI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-07-02 Fiedler Konstantin (Chief Operating Officer) Sale 994 136.66 135,840
2018-07-02 Doherty Michael J (Head of Product Development) Sale 2,675 136.66 365,565
2018-07-02 Nallicheri Melanie (Chief Business Officer) Sale 2,008 136.66 274,413
2018-07-02 Cox Troy (Chief Executive Officer) Sale 1,402 136.66 191,597
2018-07-02 Hesslein Robert W. (SVP and General Counsel) Sale 2,520 136.66 344,383
2018-07-02 Ryan Jason (Chief Financial Officer) Sale 3,403 136.66 465,053
2018-07-02 Miller Vincent A. (Chief Medical Officer) Sale 2,909 136.66 397,543
2018-06-15 Pellini Michael J (Director) Sale 3,500 105.45 369,075
2018-05-21 Miller Vincent A. (Chief Medical Officer) Sale 1,570 85.00 133,450
2018-05-21 Miller Vincent A. (Chief Medical Officer) Option Ex 1,570 29.94 47,005
2018-05-16 Cox Troy (Chief Executive Officer) Sale 2,157 77.10 166,304
2018-05-15 Pellini Michael J (Director) Sale 3,500 76.05 266,175
2018-05-07 Cox Troy (Chief Executive Officer) Sale 7,063 70.01 494,480
2018-04-16 Ryan Jason (Chief Financial Officer) Sale 3,449 74.30 256,260
2018-04-16 Miller Vincent A. (Chief Medical Officer) Sale 3,283 74.02 243,007
2018-04-16 Pellini Michael J (Director) Sale 3,500 74.65 261,275
2018-04-03 Doherty Michael J (Head of Product Development) Sale 2 72.40 144
2018-04-03 Ryan Jason (Chief Financial Officer) Sale 1 72.40 72
2018-04-03 Pellini Michael J (Director) Sale 13,659 70.28 959,954
2018-04-02 Fiedler Konstantin (Chief Operating Officer) Sale 358 74.88 26,807
2018-04-02 Doherty Michael J (Head of Product Development) Sale 8,190 74.87 613,185
2018-04-02 Nallicheri Melanie (Chief Business Officer) Sale 1,253 74.88 93,824
2018-04-02 Hesslein Robert W. (SVP and General Counsel) Sale 1,585 74.88 118,684
2018-04-02 Hesslein Robert W. (SVP and General Counsel) Option Ex 2,344 7.12 16,689
2018-04-02 Ryan Jason (Chief Financial Officer) Sale 6,139 76.21 467,853
2018-04-02 Miller Vincent A. (Chief Medical Officer) Sale 2,883 74.93 216,023
2018-03-15 Ryan Jason (Chief Financial Officer) Sale 15,000 78.26 1,173,900
2018-03-15 Ryan Jason (Chief Financial Officer) Option Ex 15,000 29.63 444,450
2018-03-15 Pellini Michael J (Director) Sale 3,500 78.29 274,015
2018-02-20 Miller Vincent A. (Chief Medical Officer) Sale 48,819 80.94 3,889,389
2018-02-20 Miller Vincent A. (Chief Medical Officer) Option Ex 18,819 17.79 271,646
2018-02-15 Cox Troy (Chief Executive Officer) Sale 9,012 67.22 605,786
2018-02-15 Ryan Jason (Chief Financial Officer) Sale 15,000 67.53 1,012,950
2018-02-15 Ryan Jason (Chief Financial Officer) Option Ex 15,000 29.63 444,450
2018-02-15 Pellini Michael J (Director) Sale 17,324 67.69 1,172,661
2018-02-13 Kafka Steven J. (President & COO) Sale 29,791 61.55 1,833,636
2018-02-07 Cox Troy (Chief Executive Officer) Sale 26,713 70.13 1,873,382
2018-02-07 Kafka Steven J. (President & COO) Sale 23,064 70.13 1,617,478
2018-01-29 Miller Vincent A. (Chief Medical Officer) Sale 4,400 75.00 330,000
2018-01-29 Miller Vincent A. (Chief Medical Officer) Option Ex 4,400 4.16 18,304
2018-01-22 Miller Vincent A. (Chief Medical Officer) Sale 17,187 70.27 1,207,730
2018-01-22 Miller Vincent A. (Chief Medical Officer) Option Ex 17,187 .84 14,437
2018-01-17 Miller Vincent A. (Chief Medical Officer) Sale 5,534 65.39 361,868
2018-01-17 Miller Vincent A. (Chief Medical Officer) Option Ex 5,534 .84 4,648
2018-01-17 Pellini Michael J (Director) Sale 10,150 65.52 665,028
2018-01-16 Hesslein Robert W. (SVP and General Counsel) Sale 18,021 64.30 1,158,750
2018-01-16 Ryan Jason (Chief Financial Officer) Sale 21,035 64.38 1,354,233
2018-01-16 Ryan Jason (Chief Financial Officer) Option Ex 20,000 29.63 592,600
2018-01-16 Kafka Steven J. (President & COO) Sale 4,148 65.71 272,565
2018-01-16 Miller Vincent A. (Chief Medical Officer) Sale 9,221 65.26 601,762
2018-01-16 Miller Vincent A. (Chief Medical Officer) Option Ex 5,408 .84 4,542
2018-01-16 Pellini Michael J (Director) Sale 27,138 64.19 1,741,988
2018-01-03 Kafka Steven J. (President & COO) Sale 2,257 64.00 144,448
2018-01-02 Nallicheri Melanie (Chief Business Officer) Sale 1,494 64.00 95,616
2018-01-02 Hesslein Robert W. (SVP and General Counsel) Sale 1,864 64.00 119,296
2018-01-02 Ryan Jason (Chief Financial Officer) Sale 2,336 64.00 149,504
2018-01-02 Kafka Steven J. (President & COO) Sale 157 64.00 10,048
2018-01-02 Miller Vincent A. (Chief Medical Officer) Sale 2,349 64.00 150,336
2017-12-13 Pellini Michael J (Director) Sale 48,746 61.71 3,008,115
2017-12-13 Jones Evan/ Fa (Director) Sale 1,400 62.05 86,870
2017-12-06 Kafka Steven J. (President & COO) Sale 5,774 58.57 338,183
2017-12-06 Kafka Steven J. (President & COO) Option Ex 5,774 4.16 24,019
2017-12-06 Pellini Michael J (Director) Sale 20,947 58.11 1,217,230
2017-12-06 Jones Evan/ Fa (Director) Sale 600 57.88 34,728
2017-12-05 Ryan Jason (Chief Financial Officer) Sale 21,726 61.26 1,330,934
2017-12-05 Ryan Jason (Chief Financial Officer) Option Ex 21,726 3.60 78,213
2017-12-05 Miller Vincent A. (Chief Medical Officer) Sale 20,000 61.17 1,223,400
2017-12-05 Pellini Michael J (Director) Sale 9,053 61.47 556,487
2017-12-05 Jones Evan/ Fa (Director) Sale 5,900 60.94 359,546
2017-11-02 Ryan Jason (Chief Financial Officer) Sale 9,731 50.00 486,550
2017-10-13 Kafka Steven J. (President & COO) Sale 3,361 44.62 149,967
2017-10-12 Ryan Jason (Chief Financial Officer) Sale 1,152 45.05 51,897
2017-10-02 Nallicheri Melanie (Chief Business Officer) Sale 5,440 38.80 211,071
2017-10-02 Hesslein Robert W. (SVP and General Counsel) Sale 2,165 38.80 84,002
2017-10-02 Ryan Jason (Chief Financial Officer) Sale 3,154 38.80 122,375
2017-10-02 Kafka Steven J. (President & COO) Sale 3,201 38.80 124,198
2017-10-02 Miller Vincent A. (Chief Medical Officer) Sale 2,944 38.80 114,227
2017-10-02 Pellini Michael J (Director) Sale 4,349 38.80 168,741
2017-08-09 Pellini Michael J (Director) Sale 30,000 39.52 1,185,600
2017-08-09 Daly David (Chief Commercial Officer) Sale 46,872 39.50 1,851,444
2017-08-09 Daly David (Chief Commercial Officer) Option Ex 46,872 22.24 1,042,433
2017-08-08 Yeshwant Krishna (Director) Sale 4,800 40.01 192,048
2017-08-04 Yeshwant Krishna (Director) Sale 18,072 36.85 665,953
2017-08-04 Yeshwant Krishna (Director) Option Ex 13,385 24.21 324,050
2017-07-14 Kafka Steven J. (President & COO) Sale 11,781 39.15 461,226
2017-07-13 Ryan Jason (Chief Financial Officer) Sale 5,084 39.77 202,190
2017-07-06 Hesslein Robert W. (SVP and General Counsel) Sale 5,070 38.84 196,918
2017-07-06 Ryan Jason (Chief Financial Officer) Sale 6,683 38.84 259,567
2017-07-06 Kafka Steven J. (President & COO) Sale 7,398 38.84 287,338
2017-07-06 Miller Vincent A. (Chief Medical Officer) Sale 5,408 38.84 210,046
2017-07-06 Pellini Michael J (Director) Sale 15,856 38.84 615,847
2017-07-06 Daly David (Chief Commercial Officer) Sale 6,316 38.84 245,313
2017-07-05 Kafka Steven J. (President & COO) Sale 12,310 38.98 479,843
2017-06-08 Hesslein Robert W. (SVP and General Counsel) Option Ex 7,033 5.64 39,666
2017-06-02 Ryan Jason (Chief Financial Officer) Sale 5,573 40.00 222,920
2017-06-01 Daly David (Chief Commercial Officer) Sale 555 38.30 21,256
2017-05-12 Hesslein Robert W. (SVP and General Counsel) Sale 1,009 33.87 34,174
2017-04-18 Ryan Jason (Chief Financial Officer) Sale 503 34.55 17,378
2017-04-18 Kafka Steven J. (President & COO) Sale 4,405 34.55 152,192
2017-04-03 Hesslein Robert W. (SVP and General Counsel) Sale 1,233 31.96 39,406
2017-04-03 Ryan Jason (Chief Financial Officer) Sale 1,233 31.96 39,406
2017-04-03 Kafka Steven J. (President & COO) Sale 2,157 31.96 68,937
2017-04-03 Miller Vincent A. (Chief Medical Officer) Sale 1,353 31.96 43,241
2017-04-03 Pellini Michael J (Director) Sale 1,700 31.96 54,332
2017-04-03 Daly David (Chief Commercial Officer) Sale 2,070 31.96 66,157
2017-03-16 Hesslein Robert W. (SVP and General Counsel) Sale 6,231 31.67 197,335
2017-03-16 Ryan Jason (Chief Financial Officer) Sale 12,500 31.68 396,000
2017-03-16 Ryan Jason (Chief Financial Officer) Option Ex 12,500 2.50 31,250
2017-03-08 Pellini Michael J (Director) Sale 9,489 34.28 325,282
2017-03-08 Pellini Michael J (Director) Option Ex 9,489 7.12 67,561
2017-03-07 Pellini Michael J (Director) Sale 30,511 34.31 1,046,832
2017-03-07 Pellini Michael J (Director) Option Ex 30,511 7.12 217,238
2017-03-01 Daly David (Chief Commercial Officer) Sale 541 25.12 13,589
2017-02-08 Kafka Steven J. (President & COO) Sale 10,415 23.24 242,044
2017-01-13 Ryan Jason (Chief Financial Officer) Sale 1,777 19.00 33,763
2017-01-04 Hesslein Robert W. (SVP and General Counsel) Sale 1,426 18.49 26,366
2017-01-04 Ryan Jason (Chief Financial Officer) Sale 1,426 18.49 26,366
2017-01-04 Kafka Steven J. (President & COO) Sale 2,376 18.49 43,932
2017-01-04 Miller Vincent A. (Chief Medical Officer) Sale 1,267 18.49 23,426
2017-01-04 Pellini Michael J (Chief Executive Officer) Sale 3,491 18.49 64,548
2017-01-04 Daly David (Chief Commercial Officer) Sale 2,370 18.49 43,821
2017-01-03 Hesslein Robert W. (SVP and General Counsel) Sale 3,256 17.41 56,686
2017-01-03 Ryan Jason (Chief Financial Officer) Sale 3,239 17.41 56,390
2017-01-03 Kafka Steven J. (President & COO) Sale 6,014 17.41 104,703
2017-01-03 Miller Vincent A. (Chief Medical Officer) Sale 3,506 17.41 61,039
2017-01-03 Pellini Michael J (Chief Executive Officer) Sale 11,146 17.41 194,051
2017-01-03 Daly David (Chief Commercial Officer) Sale 2,727 17.41 47,477
2016-11-22 Kafka Steven J. (President & COO) Sale 4,814 23.00 110,722
2016-11-22 Kafka Steven J. (President & COO) Option Ex 4,814 4.16 20,026
2016-11-18 Kafka Steven J. (President & COO) Sale 1,459 23.06 33,644
2016-11-18 Kafka Steven J. (President & COO) Option Ex 1,459 4.16 6,069
2016-11-16 Kafka Steven J. (President & COO) Sale 1,000 23.00 23,000
2016-11-16 Kafka Steven J. (President & COO) Option Ex 1,000 4.16 4,160
2016-10-20 Ryan Jason (Chief Financial Officer) Sale 506 22.45 11,359
2016-10-20 Kafka Steven J. (President & COO) Sale 4,427 23.00 101,821
2016-10-04 Hesslein Robert W. (SVP and General Counsel) Sale 1,220 23.65 28,853
2016-10-04 Ryan Jason (Chief Financial Officer) Sale 1,220 23.65 28,853
2016-10-04 Kafka Steven J. (President & COO) Sale 2,032 23.65 48,056
2016-10-04 Miller Vincent A. (Chief Medical Officer) Sale 1,084 23.65 25,636
2016-10-04 Pellini Michael J (Chief Executive Officer) Sale 2,629 23.65 62,175
2016-10-04 Daly David (Chief Commercial Officer) Sale 2,045 23.65 48,364
2016-10-03 Kafka Steven J. (President & COO) Sale 103 23.04 2,373
2016-10-03 Miller Vincent A. (Chief Medical Officer) Sale 258 23.04 5,944
2016-09-20 Kafka Steven J. (President & COO) Sale 9,469 23.70 224,415
2016-09-20 Kafka Steven J. (President & COO) Option Ex 7,850 4.16 32,656
2016-09-01 Daly David (Chief Commercial Officer) Sale 551 20.48 11,284
2016-08-19 Ryan Jason (Chief Financial Officer) Sale 13,863 23.93 331,672
2016-08-19 Ryan Jason (Chief Financial Officer) Option Ex 5,000 7.12 35,600
2016-08-09 Hesslein Robert W. (SVP and General Counsel) Option Ex 9,377 5.64 52,886
2016-08-05 Kafka Steven J. (President & COO) Sale 10,000 24.16 241,600
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of FMI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Foundation Medicine, Inc. (symbol FMI, CIK number 1488613) see the Securities and Exchange Commission (SEC) website.